Hobey Baker Award winner suspended for banned substance
PUBLICATION
Dorin Canaday
April 18, 2022 (5:49 PM)
Monday morning, the United States Anti-Doping Agency announced that the 2022 Hobey Baker Award winner would receive a six-month suspension for a positive test of the banned substance.
Dryden McKay, a goaltender for the Minnesota State University and Hobey Baker winner as NCAA men's hockey's top player, received the suspension because of a small trace of Ostarine found in his urine.
McKay had to give a urine sample as he was selected as an extra for the U.S. Men's Olympic team for the 2022 Winter Games in Beijing, China. When his test returned positive, he was shocked and later found out that the banned substance was found in Quercetin, a plant-based antioxidant and anti-inflammatory that he was using as an immune booster against COVID.
The initial sentence was rumoured to be for four years, but he received only a six-month suspension because he proved its origin was a falsely-marked supplement.
Source: NHL Insider Elliotte Friedman on Twitter
|
10 hours ago | By Austin Sabourin Boston Bruins Issue An Emotional Statement Following The Passing Of A Former Bruins Player |
|
11 hours ago | By Austin Sabourin Injury: Mid-Game Injury Changes Things For The Boston Bruins and Edmonton Oilers Game |
|
15 hours ago | By Austin Sabourin Healthy Scratched: Two Boston Bruins Players Confirmed As Healthy Scratches Tonight |
|
16 hours ago | By Austin Sabourin Boston Bruins Head Coach Joe Sacco Completes Surprising Roster Move |
|
17 hours ago | By Austin Sabourin A Surprising Player Was Present At Boston Bruins Practice This Morning Following Injury News |
|
18 hours ago | By Austin Sabourin Major Development: Boston Bruins Insider Issues Significant Update Regarding Lindholm's Ongoing Injury |
|
20 hours ago | By Joshua Deeds A Completed Trade For The Boston Bruins That Has Changed Things |
|
23 hours ago | By Joshua Deeds Major Development Has Surfaced Regarding Boston Bruins Superstar David Pastrnak |
Previously on Bruins Insider